FDA Investigator John R Myung

John R Myung has conducted inspections on 243 sites in 2 countries as of 05 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
243
Last Inspection Date:
05 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Brazil
FDA Investigators that have inspected at least one site in common with John R Myung:
Ademola O Daramola, Adriana Meza, Albert C Cheng, Alexandra B Pitkin, Ali Hernandez, Amalia C Himaya, Ana Djurdjevic, Ana M Pietsch, Anderson, Andrew K Haack, PhD, Andrew S Johnson, Andy B Lee, Angela Shepas, Anita Narula, PhD, Anthony E Guzman, Avery J Dennis, Barry Cherney, PhD, Benigno B Devera, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Bonnie I Needleman, Brandon R Boone, Brian Ravitch, Brien C Fox, Bruce W Benware, Burnsb, Bush, Carla J Lundi, Carol S Sanchez, Caryn M Mcnab, Cathleen A Carr Sharpe, Cathryn M Groehnert, Celena Ngo, Cheron M Portee, Christina C Santos, Christina V Santos, Christopher M Elliott, Comyar Shoghi, Corey A Cruse, Cristina E Graves, Cristina E Mosquera, Crystal Monroy, Daniel J Simonsen, Daniel W Cline, Darrin E Davis, David A Quale, David G Whitman, David Serrano, Davinna Ligons, PhD, Davis, Debbie K Giang, Deborah A Greco, Deborah L Parker, Deborah W Hsu, Debra D Devlieger, Debra J Fracassa, Deidre R Edwards, Dejon N Harris, Dennis N Hoang, Desiree C Iya, Diane Cvan Leeuwen, Doan T Nguyen, PharmD, Donna Ltartaglino Besone, Eileen T Dupont, Elizabeth M Dahl, Elizabeth Q Maccorkell, Ellen N Stewart, Elodie X Tong Lin, Erica Aspinwall Brown, Erik D Sandvig, Erika V Butler, Esther C Broner, PhD, Fe Q Reyes, Frances Namuswe, PhD, Francisco, Gabriel Craig, Gale L Glinecki, Garciam, Gene D Arcy, Geoffrey M Leist, Geraldine M Peregrin, Glenn R Archambault, Glorioso M Pama, Gordon Chu, Greg K Keshishyan, Gulshan R Anand, Gunneet Kaur, Hagstrom, Hai T Truong, Haley H Seymour, Harmon M Blanch, Haroon Vohra (NMI), Hasan A Irier, PhD, Henry E Carrillo, Herminio C Francisco, Ian J Thomson, Iris C Macinnes, Ivar J Sohn, James A Barreto, James E Bentson, James P Stallings, James R Fleckenstein, Janice Wai, Jeanne A Young, Jeanne M Weishaar, Jeannie Pradyanata, Jee Chung, PhD, Jeff M Uriarte, Jeffrey P Raimondi, Jennifer Gogley, Jennifer L Johnson, Jennifer M Gogley, Jennifer W Cheng Dobson, Jessica L Andrade, Jhakeim D Seaberry, Jimmy C Ngan, Jinnie Kokiatkulkij, Jocelyn E Massey, Joel Welch, PhD, John A Liu, John C Su, John E Emmert, John P Jorgensen, Jonathan R Ormond, Jonathan T Little, Jose O Caraballo Rivera, Joseph A Seitz, III, Joseph C Francisco, Joseph C Yen, Joseph H Lam, Joseph M Allen, Juanita Banuelos, Judy C Nepsa, Junho Pak, Justin M Runac, Ka L Wong, Kai Wang, Karla J Gibler, Katherine P Chan, Katherine P Tran, Kathleen R Jones, PhD, Katie T Duong, Kawshalya Pathiraja, Keeshunna D Daniels, Kelley, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kevin Lee, Kevin N Tran, Kevin T Gerrity, Kham Phommachanh, Khang K Pham, Khoa Nathanv Tran, Kim Lthomas Cruse, Kimberly M Lichter, Lanita F Kelley, Laura Fontan, MS, LCDR Wilfred A Darang, Leonard H Lavi, Lesley A Swanson, Lilly O Barton, Liming Zhang, Lin Liu, Lisa M Schultz, Lourdes M Countee, Marcel G Belen, Marcia B Williams, Marco A Solorio, Marcus F Yambot, Mario A Iglesias, Mark E Moen, Mark Gray, Matthew C Kristof, Maurice M Sheehan, Maxyne T Lam, Mcgrewp, Melody M Ragasa Leong, Michael D Garcia, Michael F Schuette, Michael S Call, Michelle A Marsh, Mihaly S Ligmond, Misty L Treece, Mohsen Rajabi Abhari, FDA, Natalie J Ayoub, Natalie J Reese, Naveen B Walker, Ngoc T Le, Nianna C Burns, Nicholas J Lahey, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Omotunde O Osunsanmi, Ounchith J Phabmixay, Patrick R Dimapindan, Patti A Walters, Peter S Diak, Phal K Chhun, Phillip J Sample, Phillip L Toy, Quyen T Tien, Rachel C Stanton, Randal Anderson, Randall J Plunkett, Raphelia Spisso, Rebecca I Campalans, Rebecca L Stephany, Rebecca Rodriguez, Richard W Tubb, Richmond K Yip, Robert C Hoover, Robert D Ogan, Robert D Tollefsen, Robert Darius, Rocco C Black, Rochelle A Rolnik, Rocio Guzman Velazquez, Roger F Zabinski, Romero, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Rowena S Nguyen, Ryan J Borges, Sandra I Gaul, Sara H Gabel, Sara Jdent Acosta, Sarah A Hassas, Sarah Arden, Scott R Nichols, PhD, Selene T Torres, Sherry G Gonzalez, Sidney B Priesmeyer, Sonia R Peterson, Sonya L Karsik, RAC, Sparky L Bartee, Stanley Au, Stephen G Mclane, Steven Fong, MS, PhD, Stuart W Russell, Susan I Shaffer, Sylvia A Thomas, Taichun Qin, PhD, Tamara L Alexander, Tamika White, Tanya E Malais, Terrance P Nguyen, Terri L Dodds, Terry L Boles, Thanh B Tran, Thanh M Andrews, Thao T Kwan, Thao X Tran, Theresa Kirkham (NMI), Thomas C Mclean, CFS, Timothy S Williamson, Tom Limchumroon, Tracey T Duong, Trushani T Desai, Uttaniti Limchumroon (Tom), Vien Q Le, William J Leonard, Wr Bowman, Yasamin Ameri, Yolanda D Mitchell Lee, Yumi J Hiramine, Yvette E Guillermo, Yvonne C Wilkes, Yvonne M Larsen, Yvonne T Lacour

John R Myung's Documents

Publish Date Document Type Title
December, 2023 FDA 483 Dole Packaged Foods, LLC - Form 483, 2023-12-12
May, 2011 EIR Amgen, Inc - EIR, 2011-05-20
May, 2011 FDA 483 Cardinal Health 414, LLC - Form 483, 2011-05-11
December, 2011 EIR Neutraderm, Inc. - EIR, 2011-12-02
December, 2011 FDA 483 Neutraderm, Inc. - Form 483, 2011-12-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more